Clinical trials
Recherche d’études cliniques
Recherchez uniquement dans les études cliniques enregistrées dans Biomedical Watch.
Études cliniques 574
| Étude / NCT ⇅ | Molécule ⇅ | Maladie ⇅ | Phase ⇅ | Statut ⇅ | Résultat ⇅ | Sponsor ⇅ | Pays / centres ⇅ | Période ⇅ | Détail |
|---|---|---|---|---|---|---|---|---|---|
| NCT07261631 Phase I Study of [177Lu]Lu-DFC413 in Patients With Solid Tumors |
68Ga-NNS309 | Cancer | Phase 1 | RECRUITING | En attente / non publié | Novartis Pharmaceuticals | United States, Canada, Denmark, France, Germany, Isra… | 2025-11-24 → 2029-05-09 | Ouvrir |
| NCT07554339 A Clinical Trial of Calderasib (MK-1084) and Durvalumab in People With … |
Calderasib | Cancer | Phase 3 | RECRUITING | En attente / non publié | Merck Sharp & Dohme LLC | United States, Argentina, Australia, Brazil, China, F… | 2026-06-18 → 2037-08-17 | Ouvrir |
| NCT06694454 Neoadjuvant Inhaled Azacytidine With Platinum-Based Chemotherapy and Du… |
azacytidine | Cancer | Phase 1/2 | SUSPENDED | En attente / non publié | National Cancer Institute (NCI) | United States · National Institutes of Health Clinica… | 2026-10-14 → 2034-12-31 | Ouvrir |
| NCT03924856 Perioperative Pembrolizumab (MK-3475) Plus Neoadjuvant Chemotherapy Ver… |
Pembrolizumab | Parkinson | Phase 3 | COMPLETED | En attente / non publié | Merck Sharp & Dohme LLC | United States, Australia, Belgium, Canada, Denmark, F… | 2019-06-13 → 2026-05-18 | Ouvrir |
| NCT07582159 Tafasitamab With Acalabrutinib and Venetoclax for the Treatment of Chro… |
Acalabrutinib | SEP | Phase 2 | NOT_YET_RECRUITING | En attente / non publié | City of Hope Medical Center | United States · City of Hope at Irvine Lennar, Irvine… | 2026-12-19 → 2029-04-14 | Ouvrir |
| NCT02538926 Etoposide, Prednisone, Vincristine Sulfate, Cyclophosphamide, and Doxor… |
Asparaginase | SEP | Phase 2 | WITHDRAWN | En attente / non publié | University of Washington | United States · Fred Hutchinson Cancer Research Cente… | 2018-07-01 → 2021-07-30 | Ouvrir |
| NCT00003595 Combination Chemotherapy With or Without Monoclonal Antibody Therapy in… |
Filgrastim | SEP | Phase 3 | COMPLETED | En attente / non publié | National Cancer Institute (NCI) | United States · Arthur G. James Cancer Hospital - Ohi… | 1999-01 | Ouvrir |
| NCT00818961 Donor Stem Cell Transplant in Treating Patients With High-Risk Hematolo… |
Alemtuzumab | SEP | Phase 2 | TERMINATED | En attente / non publié | Northwestern University | United States · Blood and Marrow Transplant Group of … | 2005-05 → 2012-03 | Ouvrir |
| NCT07853690 Histotripsy in Biliary Tract Cancer |
Histotripsie — HistoSonics Edison… | Cancer | Non applicable | NOT_YET_RECRUITING | En attente / non publié | HistoSonics, Inc. | United States · NYU Langone Health, New York, United … | 2026-09 → 2028-09 | Ouvrir |
| NCT02888132 Echocardiography-guided Transthoracic Radio Frequency/Laser Ablation fo… |
Echocardiography-guided transthor… | Cancer | Non applicable | UNKNOWN | En attente / non publié | Xijing Hospital | China · Ultrasound Medicine Department of Xijing Hosp… | 2016-04 | Ouvrir |
| NCT03221335 EUS-guided RFA for Solid Abdominal Neoplasms |
EUS-guided RFA | Cancer | Non applicable | RECRUITING | En attente / non publié | Chinese University of Hong Kong | Hong Kong · Department of Surgery, Prince of Wales Ho… | 2016-05 → 2027-04 | Ouvrir |
| NCT03908255 BCAA in HCC — Branched-chain Amino Acid Supplementation for Hepatocellu… |
Branch Chain Amino Acid | Cancer | Phase 2 | WITHDRAWN | En attente / non publié | Louisiana State University Health… | United States · University Medical Center New Orleans… | 2021-06-01 → 2023-12-30 | Ouvrir |
| NCT06185556 COLDFIRE-III Trial: Efficacy of Irreversible Electroporation and Stereo… |
Irreversible Electroporation | Cancer | Phase 2/3 | RECRUITING | En attente / non publié | Angiodynamics, Inc. | Netherlands · Amsterdam UMC - location VUmc, Amsterda… | 2024-08-20 → 2031-09-01 | Ouvrir |
| NCT02464761 Photodynamic Therapy for the Treatment of Vertebral Metastases |
Visudyne | Cancer | Phase 1 | COMPLETED | En attente / non publié | Sunnybrook Health Sciences Centre | Canada · Sunnybrook Health Sciences Centre, Toronto, … | 2011-06 → 2017-09-07 | Ouvrir |
| NCT06307080 Clinical Study of Multimodal Ablation Remodeling Immunosensitized PD-1 … |
Multi-mode thermal ablation device | Cancer | Non applicable | RECRUITING | En attente / non publié | Shanghai General Hospital, Shangh… | China · Shanghai General Hospital, Shanghai, China | 2023-10-08 → 2026-12-31 | Ouvrir |
| NCT02615860 TECAIN — Efficacy and Safety of TCA vs. ECA for the Treatment of AIN in… |
Surgical electrocautery (ECA) | Cancer | Non applicable | COMPLETED | En attente / non publié | University Hospital, Essen | Germany · Universitätsklinikum Essen, Klinik für Derm… | 2015-11 → 2021-12-31 | Ouvrir |
| NCT07830095 5G-Enabled Remote Robotic-Assisted Bronchoscopy-Guided Cryoablation for… |
5G-Enabled Remote Robotic-Assiste… | Cancer | Non applicable | NOT_YET_RECRUITING | En attente / non publié | Shanghai Chest Hospital | China · Shanghai Chest hospital, Shanghai, China | 2026-09-30 → 2027-12-31 | Ouvrir |
| NCT03993678 Intratumoral Injection of IP-001 Following Thermal Ablation in Patients… |
IP-001 | Cancer | Phase 1/2 | COMPLETED | En attente / non publié | Swiss Cancer Institute | Switzerland · Inselspital, Bern, Bern, Switzerland | … | 2020-10-12 → 2025-07-19 | Ouvrir |
| NCT04087980 Ablation of Prostate Tissue Utilizing Sterile Water Vapor in Patients W… |
Poseidon System | Cancer | Non applicable | COMPLETED | En attente / non publié | Francis Medical Inc. | United States · Bon Secours/Good Samaritan Hospital, … | 2020-04-10 → 2022-05-25 | Ouvrir |
| NCT03620786 HIFU for Focal Ablation of Prostate Tissue: An Observational Study |
Sonablate HIFU device | Cancer | À vérifier | RECRUITING | En attente / non publié | University of California, Los Ang… | United States · University of California, Los Angeles… | 2018-09-26 → 2028-01-31 | Ouvrir |
| NCT04803773 UFOGUIDE — MRI-guided Focused Ultrasound : Feasibility Study for the Tr… |
UFOGUIDE "patient transducer" | Cancer | Non applicable | UNKNOWN | En attente / non publié | University Hospital, Strasbourg, … | France · Hopitaux Universitaires de Strasbourg, Stras… | 2021-01-19 → 2024-11-09 | Ouvrir |
| NCT07766187 CODAH — Combination Therapy Using Durvalumab and Histotripsy for Treatm… |
Histotripsie — HistoSonics Edison… | Cancer | Phase 2 | NOT_YET_RECRUITING | En attente / non publié | HistoSonics, Inc. | United States · University of Wisconsin, Madison, Uni… | 2026-10 → 2032-08 | Ouvrir |
| NCT05642195 Evaluation of a Cancer Lysate Vaccine and Montanide (Registered Tradema… |
Montanide (Registered Trademark) … | Cancer | Phase 1/2 | SUSPENDED | En attente / non publié | National Cancer Institute (NCI) | United States · National Institutes of Health Clinica… | 2026-10-07 → 2035-12-30 | Ouvrir |
| NCT06341114 A Clinical Study Evaluating the Safety, Tolerability, Pharmacokinetic C… |
BAT8008 injection | Cancer | Phase 1/2 | ACTIVE_NOT_RECRUITING | En attente / non publié | Bio-Thera Solutions | China · Song ZhengBo, Hangzhou, China | 2024-04-12 → 2026-11-30 | Ouvrir |
| NCT04995419 A Study to Evaluate Enfortumab Vedotin (ASG-22CE) in Chinese Participan… |
Enfortumab vedotin | Cancer | Phase 2 | COMPLETED | En attente / non publié | Astellas Pharma China, Inc. | China · Site CN86001, Beijing, China | Site CN86002, … | 2021-07-22 → 2025-08-27 | Ouvrir |